Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Bevacizumab Antibody-Biotin (8I342) is a Rabbit antibody targeting Bevacizumab. Anti-Bevacizumab Antibody-Biotin (8I342) can be used in ELISA.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 40 μg | $609 | 7-10 days | 7-10 days |
| Description | Anti-Bevacizumab Antibody-Biotin (8I342) is a Rabbit antibody targeting Bevacizumab. Anti-Bevacizumab Antibody-Biotin (8I342) can be used in ELISA. |
| Synonyms | Avastin |
| Ig Type | IgG |
| Clone | 8I342 |
| Specificity | The product is specific for Bevacizumab. This antibody blocks Bevacizumab binding with VEGF165. The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibodyAnti-Bevacizumab Antibody (2I65) (TMAS-00017). |
| Application | |
| Recommended Dose | ELISA: 0.01-0.05 µg/ml |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Purification | Protein A affinity column |
| Appearance | Lyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/mL. |
| Formulation | Lyophilized with PBS, pH 7.4, containing 1% BSA and 0.02% sodium azide. |
| Research Background | Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration. As an angiogenesis inhibitor, Bevacizumab blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A). |
| Conjucates | Biotin |
| Others Formats | Unconjugated |
| Antibody Types Available | 2 |
| Immunogen | Bevacizumab |
| Stability & Storage | The lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.